Singapore arrests 195 in nationwide crackdown on e-cigarette violations, seizes dangerous 'Kpods' containing anesthesia substance

Sep.01.2025
Singapore arrests 195 in nationwide crackdown on e-cigarette violations, seizes dangerous 'Kpods' containing anesthesia substance
Singapore recently launched a nationwide operation, arresting 195 individuals for e-cigarette violations and uncovering “Kpods” e-cigarettes containing dangerous substances, which has raised health concerns.

Key Points:

 

·Singapore recently implemented a nationwide campaign that led to the arrest of 195 individuals for violations related to e-cigarette products. 

·Authorities discovered the presence of narcotics in the e-cigarette product Kpods. 

·The government has now intensified its crackdown on e-cigarettes.

 


 

On September 1, 2025 - According to a report from time.news on August 31, Singapore authorities arrested a total of 195 individuals for e-cigarette-related violations in a series of nationwide enforcement actions. They also seized e-cigarette products "Kpods" containing dangerous drugs. The operation, which took place from August 15 to August 23, demonstrates the government's determination to address the rising trend of e-cigarettes and their associated health risks.

 

The operation carried out jointly by the Singapore Police Force and the Health Sciences Authority has revealed a concerning trend of individuals possessing and using e-cigarette products containing the powerful sedative, etizolam.

 

Singapore has strict laws regarding the import, sale, and use of e-cigarettes, with potential penalties including fines or imprisonment. This reflects the government's strong opposition to e-cigarettes.

 

Authorities deployed over 270 law enforcement officers to inspect more than 1,600 individuals from 151 public entertainment venues, including bars and KTV outlets. The operation spanned seven police districts and criminal investigation departments, with support from the Central Narcotics Bureau (CNB) and Health Sciences Authority (HSA).

 

A senior official stated, "These actions demonstrate the government team's commitment to maintaining public health and safety.

 

During the two-week operation, authorities seized over 340 e-cigarettes and related components. The age of those arrested ranged from 17 to 61 years old.

 

One of the most shocking discoveries in this case was the finding of etomidate in eleven e-cigarette pods confiscated from six individuals. These pods, known as "Kpods," signal a significant escalation in the dangers associated with e-cigarettes. Etomidate is a controlled substance commonly used for sedation and anesthesia in medical settings, and its illegal use can result in severe respiratory suppression, loss of consciousness, and even death.

 

The Health Sciences Authority (HSA) stated in a release, "The presence of tolylpyrazole in these e-cigarette products is highly concerning, highlighting the risks of purchasing and using unregulated e-cigarette products.

 

In addition to arrests related to e-cigarette crimes, law enforcement officers also detained 13 individuals suspected of other unspecified crimes during the enforcement action. This group included 10 males and 3 females, ranging in age from 19 to 47 years old. This demonstrates that the crackdown yielded results beyond its initial focus on e-cigarettes.

 

The two-week enforcement operation, as part of the government's overall strategy, demonstrates Singapore's tough stance on e-cigarettes and its emphasis on public health. Further investigations are ongoing.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris Japan adds “Electric Purple” to IQOS ILUMA i range, expands to convenience stores from Feb. 3
Philip Morris Japan adds “Electric Purple” to IQOS ILUMA i range, expands to convenience stores from Feb. 3
Philip Morris Japan (PMJ) said on Jan. 29 it has introduced “Electric Purple” as a new standard color option for its IQOS ILUMA i heated tobacco device lineup, covering three models with prices unchanged. The new color will be available from Jan. 29 via the company’s official online and store channels, with sales expanding to convenience stores and some tobacco retailers from Feb. 3.
Jan.29 by 2FIRSTS.ai
BAT Japan rolls out limited-edition “Rose Quartz” colourway for glo Hilo, launches new virto click-capsule flavour
BAT Japan rolls out limited-edition “Rose Quartz” colourway for glo Hilo, launches new virto click-capsule flavour
British American Tobacco (BAT) Japan will introduce its first Valentine’s-season limited-edition colourway, “Rose Quartz,” for the glo Hilo heated tobacco device lineup, covering both the glo Hilo and glo Hilo Plus. The devices are priced at JPY 3,980 (about $25.2) and JPY 6,980 (about $44.1), respectively, and will go on sale via official channels from Feb. 9. BAT Japan will also launch a new glo Hilo-compatible virto tobacco stick variant, “virto Bright Cherry Click,” on Feb. 2.
Jan.20 by 2FIRSTS.ai
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
India has reaffirmed its 2019 ban on e-cigarettes and heated tobacco devices, effectively blocking Philip Morris International (PMI) from launching IQOS in the country despite years of lobbying. Together with Taiwan, China’s conditional opening of heated tobacco products, and Japan’s planned 2026 excise tax hikes, these moves highlight increasingly divergent national regulatory pathways—an external uncertainty shaping PMI’s smoke-free growth trajectory.
Feb.12
KDCA youth panel: health indicators worsen with grade level; liquid e-cigarette use tops cigarettes among 11th-grade students
KDCA youth panel: health indicators worsen with grade level; liquid e-cigarette use tops cigarettes among 11th-grade students
Korea Disease Control and Prevention Agency’s Youth Health Panel Survey (2025) Final Results Report says key adolescent health indicators worsen as students move up grade levels. By 11th grade, lifetime tobacco experience rose to 9.59%. Among 11th-grade girls, current use of liquid e-cigarettes (1.54%) surpassed conventional cigarettes (1.33%) for the first time.
Feb.10 by 2FIRSTS.ai
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.
Regulations
Dec.20